Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-10-078501
Filing Date
2010-04-07
Accepted
2010-04-07 16:55:59
Documents
3
Period of Report
2010-05-21
Effectiveness Date
2010-04-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 333574
2 GRAPHIC g35818g17n35.jpg GRAPHIC 10336
3 GRAPHIC g35818g95l79.jpg GRAPHIC 7061
  Complete submission text file 0001193125-10-078501.txt   359487
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22873 | Film No.: 10737502
SIC: 2835 In Vitro & In Vivo Diagnostic Substances